PanTheryx adds nearly $3 million to funding round
BOULDER – Biotechnology company PanTheryx Inc. is nearing the three-quarter mark in its effort to raise $10 million, according to a recent regulatory filing with the Securities and Exchange Commission.
Boulder-based PanTheryx has raised $7.3 million of the round that began in April 2013 through equity investments and issuing warrants and options. PanTheryx reported it had raised $4.4 million of its goal in March of last year.
PanTheryx, headed by president and chief executive Mark Braman, is working on medical nutrition products, including a treatment for children with infectious diarrhea that has shown in clinical trials to be safe and effective in replenishing nutrients lost during a bout with the disease.
SPONSORED CONTENT
How Platte River Power Authority is accelerating its energy transition
Platte River Power Authority, the community-owned wholesale electricity provider for Northern Colorado, has a history of bold initiatives.
The company also is working on foods as dietary supplements to help healthy people maintain intestinal health, and medical foods for dietary management that would be used under medical supervision.
Diarrhea, the company said, is a life-threatening global health concern, representing 11 percent of child deaths worldwide, second only to pneumonia. The World Health Organization estimates that worldwide there are 1.7 billion infectious diarrhea cases annually among children younger than age 5. Nearly 1 million children die each year from diarrhea complications, killing more children than AIDS, malaria and measles combined.
In addition to Braman, Scott Hyman and George Stagnitti are listed as executive officers of the company. Tom Washing and David Cook are listed as company directors. Washing is a partner at Sequel Venture Partners LLC, a venture capital firm in Boulder. Cook is a retired lawyer from the local office of Faegre Baker Daniels LLP. He received the Esprit Entrepreneur Lifetime Achievement Award from the Boulder Chamber in 2005.
BOULDER – Biotechnology company PanTheryx Inc. is nearing the three-quarter mark in its effort to raise $10 million, according to a recent regulatory filing with the Securities and Exchange Commission.
Boulder-based PanTheryx has raised $7.3 million of the round that began in April 2013 through equity investments and issuing warrants and options. PanTheryx reported it had raised $4.4 million of its goal in March of last year.
PanTheryx, headed by president and chief executive Mark Braman, is working on medical nutrition products, including a treatment for children with infectious diarrhea that has shown in clinical trials to be safe and effective in…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!